Literature DB >> 35186161

68Ga-PSMA-11 uptake in tracheal mucus plug - a potential pitfall.

Kunal Ramesh Chandekar1, Apurva Sood1, Rajender Kumar1, Harmandeep Singh1, Shrawan Kumar Singh2.   

Abstract

Prostate-specific membrane antigen (PSMA) PET/CT is a well-acclaimed imaging modality for prostate cancer (PCa). However, many reports have highlighted PSMA radioligand uptake in a variety of benign tumors and lesions. We report a case of PCa in which 68 Ga-PSMA-11 uptake was noted in the tracheal lumen. However, 18F-PSMA-1007 PET/CT was done on a subsequent day, which demonstrated no abnormal radiotracer uptake or morphological lesion within the tracheal lumen. This case highlights an uncommon finding of PSMA ligand uptake in a tracheal mucus plug (non-prostatic benign uptake), which may be misinterpreted as a false-positive finding.
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2021.

Entities:  

Keywords:  Mucus plug; PET/CT; Pitfall; Prostate cancer; Prostate-specific membrane antigen (PSMA); Trachea

Year:  2022        PMID: 35186161      PMCID: PMC8828821          DOI: 10.1007/s13139-021-00729-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

1.  Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.

Authors:  Hemant Bhardwaj; Maximilian Stephens; Manoj Bhatt; Paul Anthony Thomas
Journal:  Clin Nucl Med       Date:  2016-12       Impact factor: 7.794

2.  68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.

Authors:  Funda Aydin; Arzu Akçal; Betül Ünal; Sema Sezgin Göksu; Firat Güngör
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

3.  Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.

Authors:  Thomas J W Klein Nulent; Matthijs H Valstar; Bart de Keizer; Stefan M Willems; Laura A Smit; Abrahim Al-Mamgani; Ludwig E Smeele; Robert J J van Es; Remco de Bree; Wouter V Vogel
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-01-31

Review 4.  Utility of 68 Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma.

Authors:  Shankar Siva; Jason Callahan; David Pryor; Jarad Martin; Nathan Lawrentschuk; Michael S Hofman
Journal:  J Med Imaging Radiat Oncol       Date:  2017-01-24       Impact factor: 1.735

5.  Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.

Authors:  R E Carter; A R Feldman; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

6.  Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids.

Authors:  J K Troyer; M L Beckett; G L Wright
Journal:  Int J Cancer       Date:  1995-09-04       Impact factor: 7.396

Review 7.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

8.  Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?

Authors:  Robert M Hermann; Manoutschehr Djannatian; Norbert Czech; Mirko Nitsche
Journal:  Case Rep Oncol       Date:  2016-08-17

9.  Pitfalls in Gallium-68 PSMA PET/CT Interpretation-A Pictorial Review.

Authors:  Deepa Shetty; Dhruv Patel; Ken Le; Chuong Bui; Robert Mansberg
Journal:  Tomography       Date:  2018-12

10.  Expression of prostate-specific membrane antigen in normal and malignant human tissues.

Authors:  Yoshihisa Kinoshita; Katsuyuki Kuratsukuri; Steve Landas; Katsumi Imaida; Peter M Rovito; Ching Y Wang; Gabriel P Haas
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.